Here are the four latest drugs approved by the Food and Drug Administration this week.
1. Dupixent is intended to treat patients with moderate to severe eczema.
2. Zejula can now be used as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
3. Bavencio is the first treatment for metastatic Merkel cell carcinoma, a rare form of skin cancer.
4. Ocrevus is intended to treat patients with severe forms of multiple sclerosis.
More articles on supply chain:
7 must-reads for supply chain leaders this week
America's focus on technology — rather than medicine — is 'eroding our national intellect,' says pharma exec
Bill Ackman calls $4B Valeant investment 'huge mistake'